StockWatch
·
Pharmaceuticals
Board Meeting31 Jul 2026, 09:50 pm

Themis Medicare Board Meeting on Aug 13 to Approve Q1 FY27 Results

AI Summary

Themis Medicare Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda for this meeting is to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter ending June 30, 2026, along with the Limited Review Reports from the Statutory Auditors. Additionally, the company has informed its 'Designated Persons' about the closure of the Trading Window from July 1, 2026, until 48 hours after the publication of these financial results, in compliance with SEBI's Insider Trading Regulations.

Key Highlights

  • Board meeting scheduled for August 13, 2026.
  • To approve Q1 FY27 Standalone and Consolidated Financial Results.
  • Limited Review Reports to be considered.
  • Trading window closure announced for designated persons.
  • Closure is from July 1, 2026, until 48 hours post-results publication.